StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$2.34+0.08 (+3.54%)

Close on Nov 19, 2026Market cap $457.00MP/E –Yield –

Ovid Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ovid Therapeutics's pe ratio was 1.6× on Apr 29, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20221.6×−0.2
2021Dec 31, 20211.8×–

More Ovid Therapeutics figures

See a number that looks wrong?